SARS-CoV-2 Mpro-IN-13
SARS-CoV-2 Mpro-IN-13 (compound 20j) is a covalent SARS-CoV-2 Protease Mpro inhibitor with an IC50 value of 19.0 nM. SARS-CoV-2 Mpro-IN-13 processes antiviral activity with an EC50 value of 138.1 nM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C(C1CCC(F)(F)CC1)N[C@H](C2CCCCC2)C(N[C@H](COC)C(NC3(C(C(NCC4=NC=CS4)=O)=O)CCC3)=O)=O
Molecular Formula
C29H41F2N5O6S
Molecular Weight
625.73
References & Citations
[1]Huang Q, et al. Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups. Bioorg Chem. 2023 Dec 6;143:107001.|[2]Qiao Huang, et al. Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups. Bioorg Chem. 2023 Dec 6:143:107001.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog